Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats

Nephrol Dial Transplant. 2006 Apr;21(4):924-34. doi: 10.1093/ndt/gfk009. Epub 2005 Dec 29.

Abstract

Background: Otsuka Long-Evans Tokushima Fatty (OLETF) rats genetically develop diabetes which is associated with hypertension. In preliminary studies, urinary excretions of L-PGDS (lipocaline-type prostaglandin D synthase) increase before diabetic nephropathy obviously develops, and this may predict progression of renal injury following diabetes. In the present study, we attempted to define whether urinary excretions of L-PGDS behave as the predictor of development of diabetic nephropathy in OLETF rats.

Methods: We investigated alterations of urinary L-PGDS excretions during the establishment of diabetes and assessed the relationship between the L-PGDS excretions and renal function in OLETF rats. Furthermore, we treated OLETF rats with troglitazone and analysed the effects on L-PGDS metabolisms. Urinary L-PGDS was measured by immunoenzyme assay and the occurrence of L-PGDS and its mRNA in the kidney was assessed by immunohistochemistry and a PCR method.

Results: Urinary excretions of L-PGDS were significantly higher in OLETF rats than non-diabetic Long-Evans Tokushima Otsuka (LETO) rats. The excretions age-dependently increased in OLETF and this increase appeared to be due to increased glomerular permeability to L-PGDS. Messenger RNA and antigenicity of L-PGDS were demonstrated in renal tissue; however, the de novo synthesis of L-PGDS mRNA seemingly contributed to urinary L-PGDS excretions much less than glomerular filtration. Multiple regression analysis revealed that urinary L-PGDS was determined by urinary protein excretions, and not by high blood pressure per se. Conversely, urinary proteinuria in the established diabetic nephropathy was predicted by urinary L-PGDS excretions in the early stage of diabetes.

Conclusions: Urinary excretions of L-PGDS are likely to reflect the underlying increase in glomerular permeability. This property may be useful to predict forthcoming glomerular damage following diabetes in OLETF rats.

MeSH terms

  • Animals
  • Chromans / pharmacology
  • Diabetes Mellitus, Type 2 / urine
  • Diabetic Nephropathies / urine*
  • Hypoglycemic Agents / pharmacology
  • Immunoenzyme Techniques
  • Intramolecular Oxidoreductases / genetics
  • Intramolecular Oxidoreductases / urine*
  • Lipocalins
  • Proteinuria / urine*
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred OLETF
  • Renal Insufficiency / urine*
  • Thiazolidinediones / pharmacology
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Lipocalins
  • RNA, Messenger
  • Thiazolidinediones
  • Intramolecular Oxidoreductases
  • prostaglandin R2 D-isomerase
  • Troglitazone